Combined targeted inhibition of bcl-2, bcl-XL, epidermal growth factor receptor, and protein kinase A type I causes potent antitumor, apoptotic, and antiangiogenic activity.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples